NCT05118919 A Safety Study of Lactobacillus Reuteri BGP-014 in Patients With Ulcerative Colitis Status COMPLETED Phase PHASE1/PHASE2
NCT05112263 Tofacitinib Versus Cyclosporine for Steroid Refractory Acute Severe Ulcerative Colitis Status NOT_YET_RECRUITING Phase NA
NCT05104229 SAVES-IBD: Safety & Efficacy of Aspirin vs. Standard of Care for VTE Prophylaxis After IBD Surgery Status WITHDRAWN Phase PHASE3
NCT05098600 The Epidemiology, Management and Comorbidities in Alopecia Areata in Czech Republic Status COMPLETED Phase N/A
NCT05088369 Assessment of the Safety, Tolerability, and Pharmacokinetic of HM201 Status COMPLETED Phase PHASE1
NCT05084261 An Investigation of Oral BT051 in Subjects With Moderately to Severely Active Ulcerative Colitis (UC) Status COMPLETED Phase PHASE1
NCT05082428 This Study is to Describe and Evaluate Patients in Finland Treated With Tofacitinib for the Treatment of Ulcerative Colitis Using Real World Data. Status COMPLETED Phase N/A
NCT05069259 Generate Real World Data On Tofacitinib Induction Therapy and Changes In Clinical and Patient Reported Outcomes. Status TERMINATED Phase N/A
NCT05061446 Etrasimod Dose-Ranging Versus Placebo as Induction Therapy Study in Adult Japanese Subjects With Moderately to Severely Active Ulcerative Colitis Status COMPLETED Phase PHASE2
NCT05058417 Assessment of Empagliflozin as Adjuvant Therapy in Patients With Ulcerative Colitis Status WITHDRAWN Phase PHASE2
NCT05051943 A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic Response Status COMPLETED Phase N/A
NCT05030064 Clinical Study on the Fecal Microbiota Transplantation in the Treatment of Ulcerative Colitis With Depression Status UNKNOWN Phase NA
NCT05019742 Evaluation of SPH3127 in Patients With Mild-to-Moderate Ulcerative Colitis Status TERMINATED Phase PHASE2
NCT04999241 Combined Application of EEN in the Induction of Remission in PUC Status NOT_YET_RECRUITING Phase PHASE4
NCT04996797 A Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Moderately to Severely Active Ulcerative Colitis (MK-7240-005) Status COMPLETED Phase PHASE2
NCT04990245 pAtient rePorted Outcomes Linked With histoLogy in Patients With uLcerative cOlitis Status COMPLETED Phase N/A